Form 4 for HIMS Hims & Hers Health, Inc.
Accepted 2026-02-25 00:00:00 ET · period of report 2026-02-23 · accession 0001837796-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-25 | 2026-02-23 | HIMS | Dudum Andrew | CEO, Dir, 10% | A - Grant | $0.00 | +794.0K | 1.67M | +90% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-02-23 | A | A | 794,002 | $0.00 | 1,672,734 | D | — | — | (F1) Represents performance-based restricted stock units (PRSUs) earned pursuant to a previously granted award. Each PRSU represents a contingent right to receive one share of the Company's Class A common stock. The Compensation Committee of the Company's Board of Directors certified that the performance criteria established in connection with this award had been met as of February 23, 2026. In accordance with the award's terms, the shares underlying the PRSUs will be delivered to the Reporting Person on or about March 15, 2026. |